120 related articles for article (PubMed ID: 18809223)
1. Expression of apolipoprotein C-IV is regulated by Ku antigen/peroxisome proliferator-activated receptor gamma complex and correlates with liver steatosis.
Kim E; Li K; Lieu C; Tong S; Kawai S; Fukutomi T; Zhou Y; Wands J; Li J
J Hepatol; 2008 Nov; 49(5):787-98. PubMed ID: 18809223
[TBL] [Abstract][Full Text] [Related]
2. Synergism between nuclear receptors bound to specific hormone response elements of the hepatic control region-1 and the proximal apolipoprotein C-II promoter mediate apolipoprotein C-II gene regulation by bile acids and retinoids.
Kardassis D; Roussou A; Papakosta P; Boulias K; Talianidis I; Zannis VI
Biochem J; 2003 Jun; 372(Pt 2):291-304. PubMed ID: 12585964
[TBL] [Abstract][Full Text] [Related]
3. The apolipoprotein A-I/C-III/A-IV gene cluster: ApoC-III and ApoA-IV expression is regulated by two common enhancers.
Vergnes L; Taniguchi T; Omori K; Zakin MM; Ochoa A
Biochim Biophys Acta; 1997 Oct; 1348(3):299-310. PubMed ID: 9366246
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPARgamma.
Kim KH; Shin HJ; Kim K; Choi HM; Rhee SH; Moon HB; Kim HH; Yang US; Yu DY; Cheong J
Gastroenterology; 2007 May; 132(5):1955-67. PubMed ID: 17484888
[TBL] [Abstract][Full Text] [Related]
5. Expression of genes involved in lipogenesis is not increased in patients with HCV genotype 3 in human liver.
Ryan MC; Desmond PV; Slavin JL; Congiu M
J Viral Hepat; 2011 Jan; 18(1):53-60. PubMed ID: 20196803
[TBL] [Abstract][Full Text] [Related]
6. HCV core protein induces hepatic lipid accumulation by activating SREBP1 and PPARgamma.
Kim KH; Hong SP; Kim K; Park MJ; Kim KJ; Cheong J
Biochem Biophys Res Commun; 2007 Apr; 355(4):883-8. PubMed ID: 17331464
[TBL] [Abstract][Full Text] [Related]
7. Interaction of hepatitis C virus core protein with retinoid X receptor alpha modulates its transcriptional activity.
Tsutsumi T; Suzuki T; Shimoike T; Suzuki R; Moriya K; Shintani Y; Fujie H; Matsuura Y; Koike K; Miyamura T
Hepatology; 2002 Apr; 35(4):937-46. PubMed ID: 11915042
[TBL] [Abstract][Full Text] [Related]
8. Specific polymorphisms in hepatitis C virus genotype 3 core protein associated with intracellular lipid accumulation.
Jhaveri R; McHutchison J; Patel K; Qiang G; Diehl AM
J Infect Dis; 2008 Jan; 197(2):283-91. PubMed ID: 18177246
[TBL] [Abstract][Full Text] [Related]
9. The activation of peroxisome proliferator-activated receptor γ is regulated by Krüppel-like transcription factors 6 & 9 under steatotic conditions.
Escalona-Nandez I; Guerrero-Escalera D; Estanes-Hernández A; Ortíz-Ortega V; Tovar AR; Pérez-Monter C
Biochem Biophys Res Commun; 2015 Mar; 458(4):751-6. PubMed ID: 25686501
[TBL] [Abstract][Full Text] [Related]
10. Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis.
Zhou J; Febbraio M; Wada T; Zhai Y; Kuruba R; He J; Lee JH; Khadem S; Ren S; Li S; Silverstein RL; Xie W
Gastroenterology; 2008 Feb; 134(2):556-67. PubMed ID: 18242221
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor-alpha and -gamma mRNA levels are reduced in chronic hepatitis C with steatosis and genotype 3 infection.
de Gottardi A; Pazienza V; Pugnale P; Bruttin F; Rubbia-Brandt L; Juge-Aubry CE; Meier CA; Hadengue A; Negro F
Aliment Pharmacol Ther; 2006 Jan; 23(1):107-14. PubMed ID: 16393287
[TBL] [Abstract][Full Text] [Related]
12. Ku autoantigen (DNA helicase) is required for interleukins-13/-4-induction of 15-lipoxygenase-1 gene expression in human epithelial cells.
Kelavkar UP; Wang S; Badr KF
Genes Immun; 2000; 1(4):237-50. PubMed ID: 11196700
[TBL] [Abstract][Full Text] [Related]
13. Monoacylglycerol O-acyltransferase 1 is regulated by peroxisome proliferator-activated receptor γ in human hepatocytes and increases lipid accumulation.
Yu JH; Lee YJ; Kim HJ; Choi H; Choi Y; Seok JW; Kim JW
Biochem Biophys Res Commun; 2015 May; 460(3):715-20. PubMed ID: 25838202
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of fatty acid synthase promoter by hepatitis C virus core protein: genotype-3a core has a stronger effect than genotype-1b core.
Jackel-Cram C; Babiuk LA; Liu Q
J Hepatol; 2007 Jun; 46(6):999-1008. PubMed ID: 17188392
[TBL] [Abstract][Full Text] [Related]
15. Binding specificity and modulation of the human ApoCIII promoter activity by heterodimers of ligand-dependent nuclear receptors.
Lavrentiadou SN; Hadzopoulou-Cladaras M; Kardassis D; Zannis VI
Biochemistry; 1999 Jan; 38(3):964-75. PubMed ID: 9893992
[TBL] [Abstract][Full Text] [Related]
16. Role of thyroid hormone in the expression of apolipoprotein A-IV and C-III genes in rat liver.
Lin-Lee YC; Strobl W; Soyal S; Radosavljevic M; Song M; Gotto AM; Patsch W
J Lipid Res; 1993 Feb; 34(2):249-59. PubMed ID: 8429259
[TBL] [Abstract][Full Text] [Related]
17. Identification of promethin and PGLP as two novel up-regulated genes in PPARgamma1-induced adipogenic mouse liver.
Yu S; Viswakarma N; Batra SK; Sambasiva Rao M; Reddy JK
Biochimie; 2004 Nov; 86(11):743-61. PubMed ID: 15589683
[TBL] [Abstract][Full Text] [Related]
18. PPARgamma2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes.
Schadinger SE; Bucher NL; Schreiber BM; Farmer SR
Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1195-205. PubMed ID: 15644454
[TBL] [Abstract][Full Text] [Related]
19. Characterization of recombinant wild type and site-directed mutations of apolipoprotein C-III: lipid binding, displacement of ApoE, and inhibition of lipoprotein lipase.
Liu H; Talmud PJ; Lins L; Brasseur R; Olivecrona G; Peelman F; Vandekerckhove J; Rosseneu M; Labeur C
Biochemistry; 2000 Aug; 39(31):9201-12. PubMed ID: 10924113
[TBL] [Abstract][Full Text] [Related]
20. Deletion of angiotensin II type I receptor reduces hepatic steatosis.
Nabeshima Y; Tazuma S; Kanno K; Hyogo H; Chayama K
J Hepatol; 2009 Jun; 50(6):1226-35. PubMed ID: 19395110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
